These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27797984)

  • 1. Effect of characteristics of women on attendance in blind and non-blind randomised trials: analysis of recruitment data from the EPHT Trial.
    Veerus P; Fischer K; Hemminki E; Hovi SL; Hakama M
    BMJ Open; 2016 Oct; 6(10):e011099. PubMed ID: 27797984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial.
    Veerus P; Fischer K; Hakama M; Hemminki E;
    BMC Med Res Methodol; 2012 Apr; 12():44. PubMed ID: 22475112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hormone therapy on women's quality of life in the first year of the Estonian Postmenopausal Hormone Therapy trial.
    Veerus P; Hovi SL; Sevón T; Hunter M; Hemminki E
    BMC Res Notes; 2012 Apr; 5():176. PubMed ID: 22472039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who wants to join preventive trials?--Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757].
    Hovi SL; Hakama M; Veerus P; Rahu M; Hemminki E
    BMC Med Res Methodol; 2005 Apr; 5():12. PubMed ID: 15826311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757].
    Veerus P; Hovi SL; Fischer K; Rahu M; Hakama M; Hemminki E
    Maturitas; 2006 Sep; 55(2):162-73. PubMed ID: 16504428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blinding decreased recruitment in a prevention trial of postmenopausal hormone therapy.
    Hemminki E; Hovi SL; Veerus P; Sevón T; Tuimala R; Rahu M; Hakama M
    J Clin Epidemiol; 2004 Dec; 57(12):1237-43. PubMed ID: 15617949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial [ISRCTN35338757].
    Vorobjov S; Hovi SL; Veerus P; Pisarev H; Rahu M; Hemminki E
    Maturitas; 2005; 52(3-4):286-95. PubMed ID: 16055284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal hormone therapy increases use of health services: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757].
    Veerus P; Fischer K; Hovi SL; Hakama M; Rahu M; Hemminki E
    Am J Obstet Gynecol; 2006 Jul; 195(1):62-71. PubMed ID: 16813745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial.
    Veerus P; Fischer K; Hovi SL; Karro H; Rahu M; Hemminki E
    BMC Womens Health; 2008 Mar; 8():5. PubMed ID: 18366766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen with and without progestin on urinary incontinence.
    Hendrix SL; Cochrane BB; Nygaard IE; Handa VL; Barnabei VM; Iglesia C; Aragaki A; Naughton MJ; Wallace RB; McNeeley SG
    JAMA; 2005 Feb; 293(8):935-48. PubMed ID: 15728164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does hormone replacement therapy affect the use of prescription medicines in postmenopausal women: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757].
    Veerus P; Fischer K; Hovi SL; Karro H; Hemminki E
    BJOG; 2007 May; 114(5):548-54. PubMed ID: 17355268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies.
    Junghans C; Feder G; Hemingway H; Timmis A; Jones M
    BMJ; 2005 Oct; 331(7522):940. PubMed ID: 16157604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Women's Health Initiative Memory Study: findings and implications for treatment.
    Craig MC; Maki PM; Murphy DG
    Lancet Neurol; 2005 Mar; 4(3):190-4. PubMed ID: 15721829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciding to join a perinatal randomised controlled trial: experiences and views of pregnant women enroled in the Magpie Trial.
    Smyth RM; Jacoby A; Elbourne D
    Midwifery; 2012 Aug; 28(4):E478-85. PubMed ID: 21944570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.
    Kwee SH; Tan HH; Marsman A; Wauters C
    Maturitas; 2007 Sep; 58(1):83-90. PubMed ID: 17689896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
    Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE
    Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of postmenopausal hormone therapy on social activity, partner relationship, and sexual life - experience from the EPHT trial.
    Hemminki E; Veerus P; Pisarev H; Hovi SL; Topo P; Karro H
    BMC Womens Health; 2009 Jun; 9():16. PubMed ID: 19505307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.